Triglycerides
Hypertriglyceridemia and ASCVD Risk
A video series about hypertriglyceridemia, its health implications and therapeutic options for optimal management of patients.
Resources
Resources developed by IAS and its member societies
Lipoprotein(a)
The Brussels International Declaration on Lipoprotein(a) Testing and Management
The Brussels International Declaration on Lp(a) Testing and Management was co-created by the Lp(a) International Task Force and global leaders at the Lp(a) Global Summit, held in Brussels, Belgium, on March 24–25, 2025. The event, organized by FH Europe Foundation, brought together scientific experts, people with the lived experience of elevated Lp(a) and policy makers from the European Institutions and World Health Organization. The World Heart Federation, Global Heart Hub, and European Alliance for Cardiovascular Health and scientific organizations such as European Atherosclerosis Society, and International Atherosclerosis Society were formal partners.
Triglycerides
Frequency of Residual Combined Dyslipidemia and Hypertriglyceridemia in Patients with Coronary Heart Disease in 13 Countries Across 6 WHO Regions: Results from INTERASPIRE
Hypertriglyceridemia (HTG) is independently associated with risk of atherosclerotic events, even when LDL-cholesterol levels appear controlled. This INTERASPIRE study determined the frequency of HTG and residual combined dyslipidemia and their related factors in patients with coronary heart disease (CHD) from 13 countries across six World Health Organization (WHO) regions.
Familial Hypercholesterolaemia
Training Modules for Management of HeFH in Children
The aims of these two modules are to provide paediatricians and other health care professionals with information to help them in the identification and management of children and young people who have heterozygous familial hypercholesterolaemia. The modules are free to access and are made available by IAS partner, Royal College of Paediatrics and Child Health.
Primary Prevention
The Challenge of Primary Prevention
Watch the complete recording of Peter Libby, Manfredi Rizzo and Viviane Z. Rocha as they present the highlights of IAS' clinical proceedings white paper, "Unmet Needs and the Evolving Landscape of Primary Prevention in Atherosclerosis," and discuss the value and challenge of primary prevention.
Familial Hypercholesterolaemia
Implementation Strategies for Improving the Care of Familial Hypercholesterolaemia from the International Atherosclerosis Society: Next Steps in Implementation Science and Practice
This is IAS guidance's core implementation strategies to assist with the adoption of clinical recommendations into routine practice for at-risk patients and families worldwide.
Familial Chylomicronemia Syndrome
Addressing the Treatment Gap for Patients with Persistent Chylomicronemia
Persistent chylomicronemia is defined by high plasma triglycerides on several occasions that is unresponsive to conventional treatments.
Familial Chylomicronemia Syndrome
Leading Insights: A Conversation with Professors Santos and Watts
Watch the first episode of IAS’ new Leading Insights series to hear Prof. Raul Santos and Prof. Gerald Watts discuss the PALISADE study’s findings, noting how plozasiran demonstrated it can meet the treatment gap for patients with familial chylomicronemia syndrome whether the rare disease is clinically defined or genetically confirmed. IAS received an unrestricted grant from Arrowhead […]
Primary Prevention
Unmet Needs and the Evolving Landscape of Primary Prevention in Atherosclerosis
This paper presents a summary of primary prevention measures for atherosclerotic cardiovascular disease caused by elevated low-density lipoprotein cholesterol, and other cardio-metabolic risk factors such as obesity and diabetes, as well as hypertension.
Cardiovascular Risk
Spanish Resources
Lo que hay que saber en Riesgo Cardiovascular – LATAM
Serie de videos en español con especialistas en ASCVD para discusión sobre el riesgo cardiovascular en América Latina.
Familial Chylomicronemia Syndrome
Spanish Resources
Lo Que Hay Que Saber en Quilomicronemia Familiar – LATAM
Serie de videos en español con especialistas en ASCVD para discusión sobre la quilomicronemia familiar en América Latina.
Inflammation
Fanning the Flames of Atherosclerosis: Assessing and Managing Inflammatory Residual Risk
Peter Libby, MD, and Jessica M. Peña, MD, MPH, FACC, FNLA, discuss the role that inflammation plays in atherosclerosis.
Promoting the scientific understanding of atherosclerosis
Newsletters
-
The IAS e-Newsletter is a digest of the latest from the IAS and its Constituent Member Societies.
-
Going beyond statins, this resource provides the latest information about primary prevention for clinicians.
